Answers are grounded in this paper and cite their sources.
Review discusses chimeric antigen receptor therapy outcomes in treatment-resistant tumors, highlighting toxic effects.
Interview with Dr. Carl June on chimeric antigen receptor therapy. (09:04)Download This review addresses T-cell engineering and synthetic immunity, with a focus on producing durable remissions in patients with treatment-refractory tumors. Toxic effects of chimeric antigen receptor therapies include cytokine release syndrome and neurologic dysfunction.
No takes yet. Share an insight, caveat, or question.
June et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: